EVERSANA’s Post

CMS must commit to an equity-centered, transparent, and learning-focused process in the Drug Price Negotiation Program. Recommendations include robust stakeholder engagement, transparency in goals and practices, and continuous quality improvement. Read recommendations: https://bit.ly/48jV3YT IVI RMA GLOBAL, Leavitt Partners, National Pharmaceutical Council #HealthPolicy #DPNP #EquityInHealthcare

💬 Niklas Hedberg (Chief Pharmacist at 🇸🇪 The Dental and Pharmaceutical Benefits Agency, TLV) reflected on the significance of the RWE4Decisions Stakeholder Actions to Generate better Real World Evidence for HTA and Payers at our public webinar.   🎥 Watch the webinar recording & find out more about the Actions for Stakeholders: https://lnkd.in/eUs5sFWb 🔗   #RealWorldEvidence #RWE #RealWorldData #RWD #HealthTechnologyAssessment #HTA #Payers #HealthData #EHDS #HTAR #StakeholderActions 

It is critical that companies implement measures to improve data quality or risk negative reputational impact with both HCP/HCOs and the public. Discover some recommended actions to avoid submissions of flawed data and breaching the Association of the British Pharmaceutical Industry (ABPI) code. Learn more: https://bit.ly/4aFWvao #ABPI #Transparency #DataBreach

The Medicines for Europe annual conference will take place in Portmarnock next month. Many different topics will be discussed, including:  - New EU Pharmaceutical and Intellectual Property legislation - The opportunities for innovation in value added medicines - Changes to the EU medicines market relating to security of supply and green criteria for procurement and reimbursement - Challenges and opportunities for investment in manufacturing and supply chains, to ensure greater supply security Find out more information about the conference here: https://lnkd.in/eMpmTqBs

New insights from conect4children! 🌟 They recently had a chat with the management team of the new c4c legal entity: Mark Turner, Ricardo Fernandes, and Luigi Comacchio. 🤝 Discover more about their vision and insights. Watch the interview here: https://lnkd.in/eUvJivtb

🔍 Disclosure recommendations for patient organisations 🔍 Our summary of the key points for patient organisations is below. The full guidance from The Association of the British Pharmaceutical Industry (ABPI) is here: https://lnkd.in/eeU-cPGn #abpicode #clarity #compliance #confidence #patientorganisations #disclosure #transparency #uk #pharma

My colleague Executive Vice President Chris Scott recently attended the 2023 Global Health Supply Chain Summit and came away with some inspiring insights about the future of the #GlobalHealth #SupplyChain. Click 👇 to read more about what was discussed at #GHSCS2023, including governance and prospects for local pharmaceutical manufacturing. @USAID Global Health Supply Chain Program-Procurement and Supply Management https://ow.ly/aiUi30syNz3

New Fact Sheet: Key Highlights from the Guidelines on the Application of Scientific Meetings and Product Promotion Meetings! We've gathered some of the key nuances within the "Guidelines on the Application of Scientific Meetings and Product Promotion Meetings", emphasizing important aspects such as: - Promotion limits, - Terms, and - Obligations. Slide over to deepen your insights! How do you envision the future of compliance in the pharmaceutical industry, given the evolving regulatory landscape? #ScientificMeetings #ProductPromotion #ComplianceStrategies #Healthcare

Seize the potential with PRA Consultancy! Our expert team specializes in bridging the gap between international healthcare companies and GCC distributors, facilitating seamless market entry and growth opportunities. Let us guide you through the complexities of the MENA pharmaceutical landscape and unlock new pathways to success. For further assistance, reach out to us at info@pra-me.com #PRAConsultancy #MarketAccess #GCCPharma #Regulatoryaffairs #GCC #MENA